4. Unable or unwilling to comply with the prohibited concomitant medication restrictions, including but not limited to CYP3A4 and UDP-glucuronosyltransferase (UGT) inducers and inhibitors, monoamine oxidase inhibitors (MAOIs), and Nav blockers.